BioPharm Insight™ Reports the Alzheimer’s Association International…

Bapineuzumab and solanezumab, among others, were up for discussion as early AD trial candidates

(PRWeb July 30, 2012)

Read the full story at

Comments are closed.

Do NOT follow this link or you will be banned from the site!
Get email updates

Get new actionable insights and updates from BiotechBlog